Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by OHTA, M.
Right arrow Articles by MIYAKE, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OHTA, M.
Right arrow Articles by MIYAKE, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 16:289-296 (1986)
© 1986 Foundation for Promotion of Cancer Research

research-article

The Role of Surgical Resection in the Management of Small Cell Carcinoma of the Lung

MITSUO OHTA, M.D., NOBUYUKI HARA, M.D., YUKITO ICHINOSE, M.D., AKIRA MOTOHIRO, M.D., SADANORI TAKEO, M.D. and JUN MIYAKE, M.D.

Department of Chest Surgery National Kyushu Cancer Center Hospital, Fukuoka

Reprint requests: Mitsuo Ohta, M.D., Department of Chest Surgery, National Kyushu Cancer Center Hospital, Notame 3-1-1, Minami-ku, Fukuoka 815, Japan.

Received July 8, 1986; To assess the role of surgical resection in the management of small cell carcinoma of the lung, experience with 118 patients who were treated between 1973 and 1985 was reviewed. Twenty-five patients underwent surgical resection followed by combination chemotherapy in all except one. The remaining 93 pa tients were treated by combined chemotherapy and radiation therapy.

The 5-year survival rate for patients with stage I disease undergoing surgical resection was 50.8%. For all 25 patients operated on, the 5-year survival rate was 30.7%.

In the patients not operated on, only those with complete response had long-term survival, for whom the 5-year survival rate was 11.9%

We consider that surgical resection is definitely indicated in patients with stage I disease. If the response to initial chemotherapy is very good, patients with stage 11 or T3N0M0 disease also probably should receive resection. Patients with N2 disease are not candidates for resection, unless distant metastases are controlled completely by intensive chemotherapy.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Thorac. Cardiovasc. Surg.Home page
M. V. Brock, C. M. Hooker, J. E. Syphard, W. Westra, L. Xu, A. J. Alberg, D. Mason, S. B. Baylin, J. G. Herman, R. C. Yung, et al.
Surgical resection of limited disease small cell lung cancer in the new era of platinum chemotherapy: Its time has come
J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 64 - 72.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.